Ping An Biomedical (PASW) vs Vera Bradley (VRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Ping An Biomedical (PASW) has outperformed Vera Bradley (VRA) over the past year, gaining 113.2% versus a gain of 85.1%. Vera Bradley is the larger company by market cap ($142.3 million vs $3.2 million), about 44.6 times the size. Vera Bradley converts more of its revenue into profit, with a net margin of -17.7% versus -37.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PASW | VRA |
|---|---|---|
| Share price | $1.13 | $4.96 |
| Market cap | $3.19M | $142.30M |
| 1-day change | -10.32% | -8.32% |
| YTD return | +125.10% | +104.96% |
| 1-year return | +113.21% | +85.07% |
| 5-year return | — | -50.25% |
| Forward P/E | — | 45.09 |
| EPS (TTM) | $-2.38 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.80M | $269.65M |
| Revenue growth (YoY) | — | -15.42% |
| Net income (latest FY) | $-1.80M | $-47.84M |
| Gross margin | 2.78% | 46.37% |
| Operating margin | -43.05% | -11.83% |
| Net margin | -37.57% | -17.74% |
| 52-week high | $28.56 | $8.36 |
| 52-week low | $1.07 | $1.39 |
| Distance from 52-week high | -96.04% | -40.67% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +41.13% |
| Average volume | 188.54K | 623.16K |
| Shares outstanding | 2.82M | 28.69M |
| Employees | 7 | 1,360 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Apparel | Apparel |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Vera Bradley is about 44.6 times larger than Ping An Biomedical by market value ($142.30M vs $3.19M).
- PASW has outperformed VRA by 28.1 percentage points over the past year.
- Vera Bradley is more profitable, keeping -17.7 cents of every revenue dollar as net income versus -37.6 cents for Ping An Biomedical.
About Ping An Biomedical
PASW stock →Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
Consumer Discretionary · Apparel · 7 employees
About Vera Bradley
VRA stock →Vera Bradley, Inc., together with its subsidiaries, designs and manufactures women's handbags, luggage and travel items, fashion and home accessories, and gifts in the United States. It operates through two segments, Vera Bradley Direct and Vera Bradley Indirect.
Consumer Discretionary · Apparel · 1,360 employees
PASW vs VRA FAQ
Which is bigger, Ping An Biomedical or Vera Bradley?
Vera Bradley (VRA) is larger, with a market capitalization of $142.30M compared with $3.19M for Ping An Biomedical (PASW).
Which stock has performed better over the past year, PASW or VRA?
PASW returned +113.21% over the past 12 months, compared with +85.07% for VRA (price return, excluding dividends). Past performance does not predict future results.
Are Ping An Biomedical and Vera Bradley in the same industry?
Yes. Both are classified in the Apparel industry within the Consumer Discretionary sector.